Barry Teobald

990 total citations
6 papers, 535 citations indexed

About

Barry Teobald is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Barry Teobald has authored 6 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Barry Teobald's work include Receptor Mechanisms and Signaling (2 papers), Neuropeptides and Animal Physiology (2 papers) and Adenosine and Purinergic Signaling (1 paper). Barry Teobald is often cited by papers focused on Receptor Mechanisms and Signaling (2 papers), Neuropeptides and Animal Physiology (2 papers) and Adenosine and Purinergic Signaling (1 paper). Barry Teobald collaborates with scholars based in United Kingdom, Sweden and United States. Barry Teobald's co-authors include Nicholas D. Kindon, James A. Smith, Paul Leff, Paul Willis, Robert G. Humphries, John Dixon, J. A. Clegg, Anthony H. Ingall, Andrew Bailey and Wendy Tomlinson and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Barry Teobald

6 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barry Teobald United Kingdom	6	287	136	115	109	53	6	535
Bernd Jablonka Germany	7	233 0.8×	159 1.2×	93 0.8×	7 0.1×	69 1.3×	14	508
Andrew Lasslo United States	11	122 0.4×	158 1.2×	94 0.8×	9 0.1×	79 1.5×	55	431
Tammy C. Wang United States	10	113 0.4×	98 0.7×	46 0.4×	25 0.2×	52 1.0×	16	278
Kokichi Suzuki Japan	10	115 0.4×	144 1.1×	32 0.3×	7 0.1×	71 1.3×	15	399
Matthias Goebel Germany	15	201 0.7×	270 2.0×	131 1.1×	7 0.1×	17 0.3×	22	527
Daisy Pireh United States	8	172 0.6×	119 0.9×	16 0.1×	5 0.0×	44 0.8×	14	347
M. Bayés Italy	8	54 0.2×	133 1.0×	18 0.2×	18 0.2×	10 0.2×	31	308
Deborah A. Mischke United States	9	144 0.5×	133 1.0×	39 0.3×	35 0.3×	14 0.3×	12	258
Xiaozhang Zheng United States	13	102 0.4×	249 1.8×	17 0.1×	47 0.4×	10 0.2×	26	448
Masahiko Ueno Japan	10	183 0.6×	234 1.7×	25 0.2×	19 0.2×	4 0.1×	11	583

Countries citing papers authored by Barry Teobald

Since Specialization

Citations

This map shows the geographic impact of Barry Teobald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Teobald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Teobald more than expected).

Fields of papers citing papers by Barry Teobald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Teobald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Teobald. The network helps show where Barry Teobald may publish in the future.

Co-authorship network of co-authors of Barry Teobald

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Teobald. A scholar is included among the top collaborators of Barry Teobald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Teobald. Barry Teobald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Kindon, Nicholas D., Glen K. Andrews, Andrew Baxter, et al.. (2017). Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists. ACS Medicinal Chemistry Letters. 8(9). 981–986. 14 indexed citations

2.

Morley, Andrew, Bryan Roberts, Barry Teobald, et al.. (2011). Lead optimisation of pyrazoles as novel FPR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(1). 532–536. 14 indexed citations

3.

Mete, Antonio, Keith Bowers, Éric Chevalier, et al.. (2011). The discovery of AZD9164, a novel muscarinic M3 antagonist. Bioorganic & Medicinal Chemistry Letters. 21(24). 7440–7446. 13 indexed citations

4.

Penkett, Clive S., et al.. (2004). The use of temporary tethers in the meta photocycloaddition reaction. Tetrahedron. 60(12). 2771–2784. 16 indexed citations

5.

Teobald, Barry. (2002). The Nicholas reaction: the use of dicobalt hexacarbonyl-stabilised propargylic cations in synthesis. Tetrahedron. 58(21). 4133–4170. 233 indexed citations

6.

Ingall, Anthony H., John Dixon, Andrew Bailey, et al.. (1999). Antagonists of the Platelet P_2T Receptor: A Novel Approach to Antithrombotic Therapy. Journal of Medicinal Chemistry. 42(2). 213–220. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact